Todas as matérias desta categoria, das mais recentes às mais antigas.
Anthropic is in talks to buy the AI startup Decart, according to people familiar with the matter. Bloomberg Intelligence Senior Analyst Matthew Bloxham explains that Decart's so-called world models could reduce the cost of training AI by making chips more effective and that the deal could provide an important boost to Anthropic's growth.
Suzano (NYSE:SUZ) reported second-quarter 2026 revenue of R$11.6 billion, adjusted EBITDA of R$4.7 billion, and net income of R$1.8 billion as pulp and paper sales volumes increased.
HSBC economist Liz Martins comments on the outlook for Bank of England policy after the economy unexpectedly expanded in June, buoyed by sunny weather and the football World Cup. She speaks on Bloomberg Television.
HSBC economist Liz Martins comments on the outlook for Bank of England policy after the economy unexpectedly expanded in June, buoyed by sunny weather and the football World Cup. She speaks on Bloomberg Television.
Cullinan Therapeutics (NASDAQ:CGEM), Taiho Oncology, and Taiho Pharmaceutical announced that the global Phase 3 REZILIENT3 trial of zipalertinib plus platinum-based chemotherapy met its primary endpoint of progression-free survival in previously untreated patients with EGFR exon 20 insertion non-small cell lung cancer.
Global Water Resources (NASDAQ:GWRS) reported second-quarter 2026 total revenue of $17.8 million, up 24.8% year over year, as higher regulated revenue, acquisitions, and customer growth contributed to results.
Fabiana Fedeli, CIO of multi-asset at M&G Investments, says the level of concentration in Asian equity indices and the S&P is a concern, but that there are "plenty of opportunities" from a broader market perspective. "There are some real outstanding winners that are not actually in AI," Fedeli tells Bloomberg Television. "There's a lot of comfort that you can actually grow from that."
Willamette Valley Vineyards (NASDAQ:WVVI) reported a second-quarter 2026 net loss of $1.39 million, compared with net income of $92,795 in the prior-year period, as net sales declined to $10 million.
Belite Bio (NASDAQ:BLTE) reported second-quarter 2026 results and announced that the U.S. Food and Drug Administration accepted its New Drug Application for tinlarebant with Priority Review for Stargardt disease type 1.
Duolingo (NASDAQ:DUOL) announced the acquisition of Animade, a London-based animation and motion design studio, to expand its in-house Design Studio and support product experience development.
As AI adoption accelerates, India could see a sharp increase in power demand from data centers. On the Emerging podcast, Tata Power CEO Praveer Sinha and India Energy & Climate Center's Mohit Bhargava discuss whether India is in for a grid shock.
Pharming (NASDAQ:PHAR) announced the commercial launch of Joenja (leniolisib) in Japan for patients aged 4 years and older with activated PI3K delta syndrome (APDS), following its inclusion on Japan’s National Health Insurance drug price list.
